BRENSOCATIB, MOMETASONE , BRENSOCATIB, The placebo used the same excipients as that used in IMP without active drug substance. The placebo was developed as film-coated tablet same in size and appearance to the IMP.
The BiRCh Study
Phase 2 small_molecule active
Quick answer
BRENSOCATIB, MOMETASONE , BRENSOCATIB, The placebo used the same excipients as that used in IMP without active drug substance. The placebo was developed as film-coated tablet same in size and appearance to the IMP. for Chronic Rhinosinusitis without Nasal Polyps (CRSsNP) is a Phase 2 program (small_molecule) at Insmed Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Insmed Limited
- Indication
- Chronic Rhinosinusitis without Nasal Polyps (CRSsNP)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active